Prevention of hypertension abrogates early inflammatory events in the retina of diabetic hypertensive rats

Experimental Eye Research

Volumn 85, Issue 1, 2007, Pages 123-129

  Silva, Kamila C ^a   Pinto, Camila C ^a   Biswas, Subrata K ^a   Souza, Denise S ^a   Lopes de Faria, José B ^a   Lopes de Faria, Jacqueline M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

blood pressure control; diabetic retinopathy; inflammation; microglia

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDRALAZINE; HYDROCHLOROTHIAZIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOSARTAN; RESERPINE; STREPTOZOCIN; SYNAPTOTAGMIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; COMORBIDITY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE EXACERBATION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINITIS; RISK FACTOR; STREPTOZOCIN DIABETES;

ADMINISTRATION, ORAL; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETIC RETINOPATHY; DRUG COMBINATIONS; EYE PROTEINS; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LOSARTAN; MALE; MICROGLIA; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RESERPINE; RETINA; TRANSCRIPTION FACTOR RELA;

EID: 34347333411     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2007.03.008     Document Type: Article

References (30)

1. Abu el Asrar A.M., Maimone D., Morse P.H., Gregory S., and Reder A.T. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am. J. Ophthalmol. 114 (1992) 731-736
2. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336 (1997) 1066-1071
3. Boje K.M., and Arora P.K. Microglia-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587 (1992) 250-256
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72 (1976) 248-254
5. Carmo A., Cunha-Vaz J.G., Carvalho A.P., and Lopes M.C. L-arginine transport in retinas from streptozotocin diabetic rats: correlation with the level of IL-1 beta and NO synthase activity. Vision Res. 39 (1999) 3817-3823
6. Chen L., Yang P., and Kijlstra A. Distribution, markers, and functions of retinal microglia. Ocul. Immunol. Inflamm. 10 (2002) 27-39
7. Flaris N.A., Densmore T.L., Molleston M.C., and Hickey W.F. Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia 7 (1993) 34-40
8. Giulian D., Li J., Bartel S., Broker J., Li X., and Kirkpatrick J.B. Cell surface morphology identifies microglia as a distinct class of mononuclear phagocyte. J. Neurosci. 15 (1995) 7712-7726
9. Joussen A.M., Poulaki V., Mitsiades N., Kirchhof B., Koizumi K., Dohmen S., and Adamis A.P. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J. 16 (2002) 438-440
10. Joussen A.M., Poulaki V., Le M.L., Koizumi K., Esser C., Janicki H., Schraermeyer U., Kociok N., Fauser S., Kirchhof B., Kern T.S., and Adamis A.P. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 18 (2004) 1450-1452
11. Krady J.K., Basu A., Allen C.M., Xu Y., LaNoue K.F., Gardner T.W., and Levison S.W. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54 (2005) 1559-1565
12. Lieth E., Gardner T.W., Barber A.J., and Antonetti D.A. Retinal neurodegeneration: early pathology in diabetes. Clin. Experiment. Ophthalmol. 28 (2000) 3-8
13. Limb G.A., Hickman-Casey J., Hollifield R.D., and Chignell A.H. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 40 (1999) 2453-2457
14. Masuzawa K., Goto K., Jesmin S., Maeda S., Miyauchi T., Kaji Y., Oshika T., and Hori S. An endothelin type a receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina. Curr. Eye Res. 31 (2006) 79-89
15. McLeod D.S., Lefer D.J., Merges C., and Lutty G.A. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroids. Am. J. Pathol. 147 (1995) 642-653
16. Miyamoto K., Khosrof S., Bursell S.E., Rohan R., Murata T., Clermont A.C., Aiello L.P., Ogura Y., and Adamis A.P. Prevention of leukostasis and vascular leakage in streptozotocin induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc. Natl. Acad. Sci. USA. 96 (1999) 10836-10841
17. Mori F., Hikichi T., Nagaoka T., Takahashi J., Kitaya N., and Yoshida A. Inhibitory effect of losartan, an AT1 angiotensin II receptor antagonist, on increased leucocyte entrapment in retinal microcirculation of diabetic rats. Br. J. Ophthalmol. 86 (2002) 1172-1174
18. Pavan M.V., Ghini B., Castro M., and Lopes de Faria J.B. Prevention of hypertension attenuates albuminuria and renal expression of fibronectin in diabetic spontaneously hypertensive rats. Am. J. Nephrol. 23 (2003) 422-428
19. Rungger-Brandle E., Dosso A.A., and Leuenberger P.M. Glial reactivity, an early feature of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 41 (2000) 1971-1980
20. Sabbatini M., Strocchi P., Vitaioli L., and Amenta F. Changes of retinal neurons and glial fibrillary acid protein immunoreactive astrocytes in spontaneously hypertensive rats. J. Hypertens. 19 (2001) 1861-1869
21. Sabbatini M., Tomassoni D., Di Tullio M.A., and Amenta F. Neuroprotective effect of treatment with calcium antagonists on hypertensive retina. Clin. Exp. Hypertens. 24 (2002) 727-740
22. Savoia C., and Schifrin E.L. Inflammation in hypertension. Curr. Opin. Nephrol. Hypertens. 15 (2006) 152-158
23. Schrier R.W., Estacio R.O., Esler A., and Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 61 (2002) 1086-1097
24. Silveira L.A., Bacchi C.E., Pinto G.A., and Lopes de Faria J.B. The genetics of hypertension modifies the renal cell replication response induced by experimental diabetes. Diabetes 51 (2002) 1529-1534
25. Tamura H., Miyamoto K., Kiryu J., Miyahara S., Katsuta H., Hirose F., Musashi K., and Yoshimura N. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest. Ophthalmol. Vis. Sci. 46 (2005) 1440-1444
26. Tikellis C., Cooper M.E., and Thomas M.C. Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes. Int. J. Biochem. Cell Biol. 38 (2006) 737-751
27. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br. Med. J. 317 (1998) 703-713
28. Yuuki T., Kanda T., Kimura Y., Kotajima N., Tamura J., Kobayashi I., and Kishi S. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J. Diabetes Complications 15 (2001) 257-259
29. Zeng H.Y., Zhu X.A., Zhang C., Yang L.P., Wu L.M., and Tso M. Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest. Ophthalmol. Vis. Sci. 46 (2005) 2992-2999
30. Zeng X.X., Ng Y.K., and Ling E.A. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis. Neurosci. 17 (2000) 463-471